![Michael Howell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Howell
Nessuna posizione attualmente
Profilo
Michael D.
Howell is the founder of Galileo Biosystems, Inc., founded in 2020.
Dr. Howell is the founder of Mountaineer Biosciences, Inc., founded in 2022, and holds the title of President.
Former jobs include Senior Director-Translational Medicine at Incyte Corp.
from 2016 to 2020, Associate Director & Principal Scientist at MedImmune LLC from 2013 to 2016, Senior Director-Biomarker & Discovery Research at Immune Tolerance Network from 2012 to 2013, Director-Operations & Quality Control at NHS Investments (Arizona) LLC, Chief Scientific Officer at DermTech, Inc. from 2020 to 2022, Principal Scientist at Boehringer Ingelheim GmbH from 2010 to 2012, and Chief Scientific Officer at Zura Bio Ltd. from 2023 to 2024.
Education includes undergraduate studies at the University of Messiah and a doctorate from West Virginia University School of Medicine.
Posizioni attive di Michael Howell
| Società | Posizione | Inizio |
|---|
Precedenti posizioni note di Michael Howell
| Società | Posizione | Fine |
|---|---|---|
| ZURA BIO LIMITED | Direttore Tecnico/Scientifico/R&S | 15/10/2024 |
| DERMTECH | Direttore Tecnico/Scientifico/R&S | 01/11/2022 |
| INCYTE CORPORATION | Corporate Officer/Principal | 01/08/2020 |
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Corporate Officer/Principal | 01/11/2016 |
Formazione di Michael Howell
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
73
Relazioni di 1° grado
9
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
Incyte Corp.
 Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Boehringer Ingelheim GmbH
 Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Manufactures and wholesales animal health & pharmaceutical products | Health Technology |
University of Messiah
 University of Messiah Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NHS Investments (Arizona) LLC
 NHS Investments (Arizona) LLC Medical/Nursing ServicesHealth Services Markets health related products | Health Services |
Immune Tolerance Network
 Immune Tolerance Network Miscellaneous Commercial ServicesCommercial Services Provides clinical research services for infectious diseases | Commercial Services |
West Virginia University School of Medicine
 West Virginia University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DermTech, Inc.
 DermTech, Inc. Medical SpecialtiesHealth Technology Provides non-invasive genomic testing services for skincare | Health Technology |
Zura Bio Ltd.
 Zura Bio Ltd. BiotechnologyHealth Technology Operates as a multi-asset clinical-stage biotechnology company that focuses on develops novel medicines for immune and inflammatory disorders | Health Technology |
